Genertec Universal Medical subsidiary completes RMB 1 bn bond issuance

Genertec Universal Medical Group Company Limited announced the successful completion of the public issuance of its fourth tranche of corporate bonds (T4 Corporate Bonds) in the PRC by its wholly-owned subsidiary, China Universal Leasing Co., Ltd. The issuance, completed on December 4, 2025, raised a total principal amount of RMB 1 billion.

The T4 Corporate Bonds carry a basic term of five years from December 4, 2025, with a fixed interest rate of 2.25%. The issue price was RMB 100 per bond, equaling 100% of the principal value.

The bonds include specific options for both the issuer and investors. At the end of the third and fourth years, the issuer holds a repurchase option and a coupon rate adjustment option, while investors are granted a sell-back option.